NCIt definition : A humanized monoclonal antibody directed against sphingosine 1-phosphate (S1P) with
potential antiangiogenic and antineoplastic activities. Upon administration, sonepcizumab
binds S1P, which may result in the inhibition of tumor angiogenesis. S1P is the extracellular
ligand for the G protein-coupled lysophospholipid receptor EDG-1 (endothelial differentiation
gene-1).;
UNII : O4T5UXS4P2;
CAS number : 1031360-18-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1031360-18-5
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;